Anti-Human HLA-DR (MHC Class II) - DyLight® 594

Leinco Technologies
Product Code: LEI-H1638
Product Group: Primary Antibodies
CodeSizePrice
LEI-H1638-50ug50 ug£159.00
Quantity:
LEI-H1638-100ug100 ug£211.00
Quantity:
LEI-H1638-200ug200 ug£291.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: IgG2a
Antibody Clonality: Monoclonal
Antibody Clone: L243
Regulatory Status: RUO
Target Species:
  • Baboon
  • Canine (dog)
  • Chimpanzee
  • Cynomolgus Monkey
  • Human
  • Marmoset
  • Rhesus Macaque
  • Squirrel monkey
Application: Flow Cytometry
Shipping:
2-8°C
Storage:
This DyLight® 594 conjugate is stable when stored at 2-8°C. Do not freeze.

Further Information

Antigen Distribution:
HLA-DR is expressed on antigen-presenting cells, including macrophages, monocytes, DCs, and B cells, and activated T cells.
Concentration:
0.2 mg/ml
Conjugate/Tag/Label:
DyLight® 594
Format:
This DyLight® 594 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Formulation:
This DyLight® 594 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Immunogen:
Purified Recombinant Human HLA-DR Monomorphic (>98%)
Long Description:
HLA-DR antibody, clone L243, recognizes the major histocompatibility complex (MHC) class II molecule Human Leukocyte Antigen - DR isotype (HLA-DR). MHC class II is constitutively expressed on human professional antigen-presenting cells (APCs), including macrophages/monocytes, dendritic cells (DCs), and B cells, and is induced on T cells upon activation2. HLA-DR consists of two transmembrane proteins, a 35 kDa α (heavy) chain and 29 kDa β (light) chain3 encoded by the HLA-DRA and HLA-DRB1, HLA-DRB3, HLA-DRB4, and HLA-DRB5 genes, respectively, located in the HLA complex of chromosome 6. The N-terminal α1 and β1 domains form the antigen-binding groove, which binds 13-25 aa peptides derived from exogenous antigens4. On APCs, MHC class II plays a critical role in the adaptive immune response by presenting phagocytosed antigens to helper CD4 T cells. The T cell receptor (TCR)/CD3 complex of CD4 T cells interacts with peptide-MHC class II, which induces CD4 T cell activation leading to the coordination and regulation of other effector cells. CD4 molecules also bind to MHC class II, which helps augment TCR signaling5. It has also been demonstrated that MHC class II express on activated T cells are capable of antigen presentation6 and can transduce signals into T cells, enhancing T cell proliferation and activity7. HLA-DR expression is a marker of T cell activation and correlates with disease activity in patients with autoimmune disease8 and rapid progression in HIV infection9. Specific alleles of HLA-DR are associated with autoimmune diseases, including rheumatoid arthritis10.
NCBI Gene:
3122
Target:
HLA-DR Monomorphic

References

1. Moro M, Cecconi V, Martinoli C, et al. (2005) BMC Immunol. 6:24 2. Holling TM, et al. (2004) Hum Immunol. 65(4):282-90 3. Mitaksov V, (2006) J Biol Chem. 281(15):10618-25 4. Wieczorek M, et al. (2017) Front Immunol. 8:292 5. Artyomov MN, et al. (2010) Proc Natl Acad Sci USA. 107(39):16916-16921 6. Barnaba V, et al. (1994) Eur J Immunol. 24(1):71-5 7. Di Rosa F, et al. (1993) Hum Immunol. 38(4):251-60 8. Viallard JF, et al. (2001) Clin Exp Immunol. 125(3):485-491 9. Langford SE, Ananworanich J, Cooper DA. (2007) AIDS Res Ther. 2007;4:11 10. Gough SC, Simmonds MJ. (2007) Curr Genomics. 8(7):453-465